Literature DB >> 7504481

N omega-hydroxy-L-arginine, a reactional intermediate in nitric oxide biosynthesis, induces cytostasis in human and murine tumor cells.

B Chénais1, A Yapo, M Lepoivre, J P Tenu.   

Abstract

Conversion of L-arginine to L-citrulline and nitric oxide (NO) by NO synthase induced in the murine EMT-6 cells resulted in the release of a large amount of the stable reactional intermediate N omega-hydroxy-L-arginine into the extracellular medium. We have prepared [3H]N omega-hydroxy-L-arginine biosynthetically, and shown that, after its uptake, this molecule can induce cytostasis in NO synthase-deficient P-815 and U-937 tumor cells. This long-lived intermediate could behave as a supplier of NO or other toxic molecules in cell-cell interactions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504481     DOI: 10.1006/bbrc.1993.2429

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Allosteric modulation of rat brain nitric oxide synthase by the pterin-site enzyme inhibitor 4-aminotetrahydrobiopterin.

Authors:  S Pfeiffer; A C Gorren; E Pitters; K Schmidt; E R Werner; B Mayer
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

2.  Nitric oxide involvement in the toxicity of hydroxyguanidine in leukaemia HL60 cells.

Authors:  S A Everett; K A Smith; K B Patel; M F Dennis; M R Stratford; P Wardman
Journal:  Br J Cancer Suppl       Date:  1996-07

3.  Tetrahydrobiopterin redox cycling in nitric oxide synthase: evidence supports a through-heme electron delivery.

Authors:  Somasundaram Ramasamy; Mohammad Mahfuzul Haque; Mahinda Gangoda; Dennis J Stuehr
Journal:  FEBS J       Date:  2016-11-18       Impact factor: 5.542

4.  Purification and characterization of nitric oxide synthase (NOSNoc) from a Nocardia species.

Authors:  Y Chen; J P Rosazza
Journal:  J Bacteriol       Date:  1995-09       Impact factor: 3.490

5.  Characterization of the stable L-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as an NG-hydroxyl-L-arginine-nitric oxide adduct.

Authors:  M Hecker; M Boese; V B Schini-Kerth; A Mülsch; R Busse
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells.

Authors:  K Schmidt; P Klatt; B Mayer
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

7.  Schistosoma mansoni arginase shares functional similarities with human orthologs but depends upon disulphide bridges for enzymatic activity.

Authors:  Jennifer M Fitzpatrick; Jose M Fuentes; Iain W Chalmers; Thomas A Wynn; Manuel Modolell; Karl F Hoffmann; Matthias Hesse
Journal:  Int J Parasitol       Date:  2008-08-06       Impact factor: 3.981

8.  The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages.

Authors:  V Iniesta; L C Gómez-Nieto; I Corraliza
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.